DK1439885T3 - Forenklede sarcodictynderivater som antitumormidler - Google Patents
Forenklede sarcodictynderivater som antitumormidlerInfo
- Publication number
- DK1439885T3 DK1439885T3 DK02772277T DK02772277T DK1439885T3 DK 1439885 T3 DK1439885 T3 DK 1439885T3 DK 02772277 T DK02772277 T DK 02772277T DK 02772277 T DK02772277 T DK 02772277T DK 1439885 T3 DK1439885 T3 DK 1439885T3
- Authority
- DK
- Denmark
- Prior art keywords
- derivatives
- simplified
- sarcodictine
- antitumor agents
- sarcodictyin
- Prior art date
Links
- 239000002246 antineoplastic agent Substances 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229930182947 sarcodictyin Natural products 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/013—Esters of alcohols having the esterified hydroxy group bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
- C07C69/618—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety having unsaturation outside the six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/32—All rings being cycloaliphatic the ring system containing at least eleven carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0122257.9A GB0122257D0 (en) | 2001-09-14 | 2001-09-14 | Simplified sarcodictyin derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1439885T3 true DK1439885T3 (da) | 2007-01-08 |
Family
ID=9922112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02772277T DK1439885T3 (da) | 2001-09-14 | 2002-09-06 | Forenklede sarcodictynderivater som antitumormidler |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20050038112A1 (da) |
| EP (1) | EP1439885B1 (da) |
| JP (1) | JP2005519864A (da) |
| AT (1) | ATE337826T1 (da) |
| CA (1) | CA2460244A1 (da) |
| DE (1) | DE60214412T2 (da) |
| DK (1) | DK1439885T3 (da) |
| ES (1) | ES2269768T3 (da) |
| GB (1) | GB0122257D0 (da) |
| PT (1) | PT1439885E (da) |
| WO (1) | WO2003024529A1 (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107337671A (zh) * | 2016-12-31 | 2017-11-10 | 陕西科技大学 | 一类具有抗肿瘤活性的橙皮素氮杂肉桂酸酯化合物及其制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9509888D0 (en) * | 1995-05-16 | 1995-07-12 | Pharmacia Spa | Terpenoidic derivatives useful as antitumour agents |
| US5965718A (en) * | 1997-10-24 | 1999-10-12 | The Scripps Research Institute | Analogs of sarcodictyin and eleutherobin |
-
2001
- 2001-09-14 GB GBGB0122257.9A patent/GB0122257D0/en not_active Ceased
-
2002
- 2002-09-06 US US10/489,508 patent/US20050038112A1/en not_active Abandoned
- 2002-09-06 ES ES02772277T patent/ES2269768T3/es not_active Expired - Lifetime
- 2002-09-06 WO PCT/EP2002/010038 patent/WO2003024529A1/en not_active Ceased
- 2002-09-06 DE DE60214412T patent/DE60214412T2/de not_active Expired - Fee Related
- 2002-09-06 PT PT02772277T patent/PT1439885E/pt unknown
- 2002-09-06 DK DK02772277T patent/DK1439885T3/da active
- 2002-09-06 EP EP02772277A patent/EP1439885B1/en not_active Expired - Lifetime
- 2002-09-06 JP JP2003528622A patent/JP2005519864A/ja active Pending
- 2002-09-06 AT AT02772277T patent/ATE337826T1/de not_active IP Right Cessation
- 2002-09-06 CA CA002460244A patent/CA2460244A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1439885A1 (en) | 2004-07-28 |
| US20050038112A1 (en) | 2005-02-17 |
| GB0122257D0 (en) | 2001-11-07 |
| EP1439885B1 (en) | 2006-08-30 |
| DE60214412D1 (de) | 2006-10-12 |
| WO2003024529A1 (en) | 2003-03-27 |
| DE60214412T2 (de) | 2007-09-20 |
| CA2460244A1 (en) | 2003-03-27 |
| ATE337826T1 (de) | 2006-09-15 |
| PT1439885E (pt) | 2007-01-31 |
| JP2005519864A (ja) | 2005-07-07 |
| ES2269768T3 (es) | 2007-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200730502A (en) | Isoquinoline aminopyrazole derivatives, their manufacture and use as pharmaceutical agents | |
| NZ543661A (en) | Pyrazolo-quinazoline derivatives having antitumor activity and process for their preparation | |
| TW200635923A (en) | Tricyclic heterocycles, their manufacture and use as pharmaceutical agents | |
| MXPA06000302A (es) | Derivados de pirazolil-indol activos como inhibidores de cinasa, procedimientos para su preparacion y composiciones farmaceuticas que los comprenden. | |
| AU2002218167A1 (en) | N-phenyl-2-pyrimidine-amine derivatives | |
| TW200407326A (en) | Pyrimido compounds having antiproliferative activity | |
| NO20054842L (no) | Kjemiske forbindelser | |
| DE60001974D1 (de) | Derivate von flavonen, xanthonen und kumarinen | |
| TW200624431A (en) | Phthalazinone derivatives, their manufacture and use as pharmaceutical agents | |
| BRPI0413438A (pt) | derivados de pirimidilpirrol ativos como inibidores de cinase | |
| NO20055891L (no) | Kinazolinderivater som aurorakinaseinhibitorer | |
| DK1124841T3 (da) | Substituerede phenylalkenoylguanidiner, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemidler eller diagnosemidler og lægemidler, som indeholder dem | |
| GEP20105095B (en) | Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents | |
| WO2002070515A3 (en) | Chromane derivatives, process for their preparation and their use as antitumor agents | |
| TW200531688A (en) | Novel pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents | |
| NO20031410D0 (no) | Antitumorterapi innbefattende distamycinderivater | |
| TR200002801T2 (tr) | PDE IV engelleyici piridin türevleri | |
| TW200719899A (en) | Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents | |
| DK1439885T3 (da) | Forenklede sarcodictynderivater som antitumormidler | |
| TW200505913A (en) | Novel oxazole derivatives, their manufacture and use as pharmaceutical agents | |
| DE60221104D1 (de) | Substituierte diarylharnstoffe als stimulatoren der fas-vermittelten apoptose | |
| MXPA05011671A (es) | Nuevos derivados de anilina, su manufactura y su uso como agentes farmaceuticos. | |
| TW200736220A (en) | Pyridylsulfonamide derivatives, their manufacture and use as pharmaceutical agents | |
| TW200720239A (en) | Styrylsulfonamides, their manufacture and use as pharmaceutical agents | |
| TW200612914A (en) | Novel oxidized thioether derivatives, their manufacture and use as pharmaceutical agents |